New Hampshire 2026 Regular Session

New Hampshire Senate Bill SB465

Introduced
11/21/25  
Refer
11/21/25  
Report Pass
2/20/26  
Engrossed
3/16/26  
Refer
3/16/26  
Report DNP
4/15/26  

Caption

Classifying xylazine as a schedule III controlled drug.

Companion Bills

No companion bills found.

Previously Filed As

NH HB126

Relative to prescriptions for certain controlled drugs.

NH SB15

Relative to establishing a mandatory minimum sentence for the crime of distribution of a controlled drug with death resulting.

NH HB226

Relative to the use of drug checking equipment.

NH SB250

Relative to pharmacist administration of long-acting injectable drugs.

NH HB473

Criminalizing multiple forms of exposing children to controlled substances and allowing law enforcement to take a child into protective custody for screening and testing in an instance of suspected or actual criminal exposure to controlled substances.

NH SB58

Relative to venue in criminal prosecutions of distribution of a controlled drug with death resulting.

NH SB14

Relative to the penalty for certain fentanyl-related offenses; relative to establishing a mandatory minimum sentence for the crime of distribution of a controlled drug with death resulting; and relative to amending the penalties for the possession and use of a quantity of psilocybin for persons 18 years of age or older.

NH SB254

Relative to controlled substance inventories and relative to surrogate parent criminal history records checks.

NH SB256

Relative to the affordability and safety of clinician administered drugs.

NH HB732

To enhance informed consent and accountability in psychotropic drug prescriptions for children under Medicaid.

Similar Bills

No similar bills found.